Introduction

In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is the most rapid. However, the commercial opportunity still exists for developers who can differentiate their antipsychotics with reformulation and indication expansion strategies.

Reasons to Purchase

*Quantify the performance of key marketed and pipeline antipsychotic drugs in the seven major markets over the period 2008 to 2018.

*Dissect the split of the sales forecast by country, by molecule, by brand, and by indcation for key products.

*Identify the leading brands in this drug class over the next 10 years and understand the key factors driving their success.


Report Highlights

[Studien Infos ausblenden]